PRINCIPAL FINANCIAL GROUP INC - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 189 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRINCIPAL FINANCIAL GROUP INC ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$110,005
-95.1%
25,464
-92.5%
0.00%
-100.0%
Q2 2023$2,223,874
-6.6%
337,462
-3.8%
0.00%0.0%
Q1 2023$2,381,714
-9.4%
350,768
-1.4%
0.00%0.0%
Q4 2022$2,628,438
-26.5%
355,675
-1.7%
0.00%
-33.3%
Q3 2022$3,575,000
-15.0%
361,785
-6.2%
0.00%0.0%
Q2 2022$4,205,000
-7.2%
385,718
-3.7%
0.00%0.0%
Q1 2022$4,530,000
-31.4%
400,524
-4.8%
0.00%
-25.0%
Q4 2021$6,600,000
-13.6%
420,623
-5.6%
0.00%
-20.0%
Q3 2021$7,637,000
-21.2%
445,556
-1.2%
0.01%
-16.7%
Q2 2021$9,697,000
+43.1%
450,792
-0.1%
0.01%
+20.0%
Q1 2021$6,778,000
+16.0%
451,261
+1.5%
0.01%
+25.0%
Q4 2020$5,842,000
+53.3%
444,621
+12.7%
0.00%
+33.3%
Q3 2020$3,812,000
-18.5%
394,632
-3.5%
0.00%
-25.0%
Q2 2020$4,677,000
+9.3%
408,857
-1.0%
0.00%
-20.0%
Q1 2020$4,278,000
-39.3%
412,975
-3.8%
0.01%
-16.7%
Q4 2019$7,043,000
+26.2%
429,168
+2.1%
0.01%
+20.0%
Q3 2019$5,580,000
-6.8%
420,188
-1.1%
0.01%0.0%
Q2 2019$5,985,000
-24.5%
424,779
-1.5%
0.01%
-28.6%
Q1 2019$7,931,000
-30.0%
431,041
-0.5%
0.01%
-41.7%
Q4 2018$11,323,000
+11.8%
433,340
-1.8%
0.01%
+33.3%
Q3 2018$10,127,000
+164.5%
441,249
+106.3%
0.01%
+125.0%
Q3 2017$3,829,000
+10.6%
213,898
+0.7%
0.00%
+33.3%
Q2 2017$3,462,000
+16.5%
212,398
+0.1%
0.00%
-25.0%
Q1 2017$2,972,000
-13.5%
212,275
-1.4%
0.00%0.0%
Q4 2016$3,434,000
+0.7%
215,275
+5.1%
0.00%0.0%
Q3 2016$3,409,000
+49.6%
204,849
+0.6%
0.00%
+33.3%
Q2 2016$2,278,000
+30.7%
203,600
-2.4%
0.00%0.0%
Q1 2016$1,743,000
-10.2%
208,5000.0%0.00%0.0%
Q4 2015$1,941,000
-17.5%
208,5000.0%0.00%
-25.0%
Q3 2015$2,352,000
-10.2%
208,500
+1.1%
0.00%0.0%
Q2 2015$2,618,000
+39.6%
206,300
+2.3%
0.00%
+33.3%
Q1 2015$1,875,000
-30.5%
201,635
+7.0%
0.00%
-25.0%
Q4 2014$2,699,000
+32.0%
188,500
-4.3%
0.00%
+33.3%
Q3 2014$2,045,000
-37.0%
197,013
-1.8%
0.00%
-40.0%
Q2 2014$3,245,000
+5.5%
200,553
+6.0%
0.01%0.0%
Q1 2014$3,075,000
+20.8%
189,200
-7.8%
0.01%0.0%
Q4 2013$2,546,000
+100.2%
205,185
+76.9%
0.01%
+66.7%
Q3 2013$1,272,000
+968.9%
115,985
+686.9%
0.00%
Q2 2013$119,00014,7390.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Palo Alto Investors LP 2,491,200$27,154,0002.37%
Profit Investment Management, LLC 281,890$3,071,0002.26%
Sio Capital Management, LLC 488,965$5,330,0002.00%
Zebra Capital Management LLC 14,766$161,0000.47%
Prairiewood Capital, LLC 50,165$547,0000.43%
TANG CAPITAL MANAGEMENT LLC 256,696$2,798,0000.42%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$1,700,0000.29%
GLOBEFLEX CAPITAL L P 100,843$1,099,0000.27%
Epoch Investment Partners, Inc. 2,757,646$30,059,0000.18%
EMC Capital Management 16,185$176,0000.15%
View complete list of VANDA PHARMACEUTICALS INC shareholders